A few weeks back we took a look at Cellanome who seem to be developing a single cell analysis platform. Today I thought it would be interesting to look at Narwhal Bio, who also seem to be developing a, perhaps related, single cell platform.
Narwhal Bio was founded in 2021, I couldn’t find any funding announcements, and only a couple of employees on LinkedIn. They also appear to be in stealth with almost no public information available on the company.
We’re therefore forced to go patent hunting…